BSF Enterprise Plc (LSE:BSFA) — Market Cap & Net Worth
Market Cap & Net Worth: BSF Enterprise Plc (BSFA)
BSF Enterprise Plc (LSE:BSFA) has a market capitalization of $27.33K (GBX224.66 Million) as of May 3, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31196 globally and #1246 in its home market, demonstrating a 16.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BSF Enterprise Plc's stock price GBX1.75 by its total outstanding shares 128374437 (128.37 Million). Analyse BSFA operating cash flow to see how efficiently the company converts income to cash.
BSF Enterprise Plc Market Cap History: 2019 to 2026
BSF Enterprise Plc's market capitalization history from 2019 to 2026. Data shows change from $78.10K to $27.33K (-14.36% CAGR).
BSF Enterprise Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BSF Enterprise Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.56x
BSF Enterprise Plc's market cap is 0.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $160.10K | $12.94K | -$1.50 Million | 12.37x | N/A |
| 2024 | $37.10K | $57.82K | -$1.67 Million | 0.64x | N/A |
| 2025 | $29.68K | $52.84K | -$1.11 Million | 0.56x | N/A |
Competitor Companies of BSFA by Market Capitalization
Companies near BSF Enterprise Plc in the global market cap rankings as of May 3, 2026.
Key companies related to BSF Enterprise Plc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
BSF Enterprise Plc Historical Marketcap From 2019 to 2026
Between 2019 and today, BSF Enterprise Plc's market cap moved from $78.10K to $ 27.33K, with a yearly change of -14.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX27.33K | -7.89% |
| 2025 | GBX29.68K | -20.00% |
| 2024 | GBX37.10K | -76.83% |
| 2023 | GBX160.10K | -38.81% |
| 2022 | GBX261.63K | +204.55% |
| 2021 | GBX85.91K | -26.67% |
| 2020 | GBX117.15K | +50.00% |
| 2019 | GBX78.10K | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of BSF Enterprise Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $27.33K USD |
| MoneyControl | $27.33K USD |
| MarketWatch | $27.33K USD |
| marketcap.company | $27.33K USD |
| Reuters | $27.33K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BSF Enterprise Plc
BSF Enterprise Plc develops and commercializes cutting-edge tissue-engineered solutions. It offers lab-grown leather, cultivated meat, and corneal repair technologies. The company was incorporated in 2018 and is based in London, United Kingdom.